{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:42Z","timestamp":1759401522513},"reference-count":48,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.vaccine.2005.04.022","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T11:45:06Z","timestamp":1115898306000},"page":"4375-4384","source":"Crossref","is-referenced-by-count":15,"title":["Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c"],"prefix":"10.1016","volume":"23","author":[{"given":"H. Martin","family":"Vordermeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reno","family":"Pontarollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Karvonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cockle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahavir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorne A.","family":"Babiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Glyn","family":"Hewinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"van Drunen Littel-van Den Hurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.04.022_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm0598supp-475","article-title":"Living up to the legacy","volume":"4","author":"Nossal","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2005.04.022_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1471-4906(01)01865-8","article-title":"TB vaccines: progress and problems","volume":"22","author":"Andersen","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389450024605436","article-title":"The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer","volume":"3","author":"Jackson","year":"2002","journal-title":"Curr Drug Targets"},{"year":"1997","series-title":"Bovine tuberculosis in cattle and badgers","author":"Krebs","key":"10.1016\/j.vaccine.2005.04.022_bib4"},{"key":"10.1016\/j.vaccine.2005.04.022_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1472-9792(02)00062-8","article-title":"Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics","volume":"83","author":"Hewinson","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2005.04.022_bib6","doi-asserted-by":"crossref","unstructured":"Skinner M, Wedlock DN, de Lisle GW, Cooke MM, Tascon R, Ferraz JC, et al. The order of a prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis, Infect Immun 2005, in press.","DOI":"10.1128\/IAI.73.7.4441-4444.2005"},{"key":"10.1016\/j.vaccine.2005.04.022_bib7","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1128\/IAI.71.9.4901-4907.2003","article-title":"A DNA prime: BCG boost vaccination strategy in cattle induces protection against bovine tuberculosis","volume":"71","author":"Skinner","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.022_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib9","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/IAI.70.10.5446-5453.2002","article-title":"Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family","volume":"70","author":"Skjot","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.022_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-2-10-research0044","article-title":"The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria","volume":"2","author":"Gey Van Pittius","year":"2001","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0966-842X(02)02345-4","article-title":"The ESAT-6\/WXG100 superfamily and a new Gram-positive secretion system?","volume":"10","author":"Pallen","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib12","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1128\/IAI.71.4.1980-1987.2003","article-title":"Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes","volume":"71","author":"Vordermeier","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.022_bib13","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.vaccine.2004.11.030","article-title":"Protective immunity against Mycobacterium bovis induced by vaccination with Rv3019c-a member of the esat-6 gene family","volume":"23","author":"Hogarth","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/17.12.1236","article-title":"ProPred: prediction of HLA-DR binding sites","volume":"17","author":"Singh","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2005.04.022_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0264-410X(02)00378-X","article-title":"CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein","volume":"21","author":"Ioannou","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib16","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1128\/JVI.76.18.9002-9010.2002","article-title":"The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides","volume":"76","author":"Ioannou","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-2427(01)00379-8","article-title":"Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs","volume":"84","author":"Pontarollo","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib18","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/S0264-410X(02)00216-5","article-title":"CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D","volume":"20","author":"Rankin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib19","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0264-410X(00)00238-3","article-title":"Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test","volume":"19","author":"Vordermeier","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0378-1135(03)00046-4","article-title":"Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting","volume":"93","author":"Vordermeier","year":"2003","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib21","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/IAI.70.6.3026-3032.2002","article-title":"Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis","volume":"70","author":"Vordermeier","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.022_bib22","unstructured":"European Economic Community. EEC directive 80\/219, amending directive 64\/432 Annexure B, Official Journal 1980; L047: 25\u201332."},{"key":"10.1016\/j.vaccine.2005.04.022_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CDLI.8.3.571-578.2001","article-title":"Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle","volume":"8","author":"Vordermeier","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib24","doi-asserted-by":"crossref","unstructured":"Wedlock DN, Vordermeier HM, Denis M, Skinner M, de Lisle GW, Hewinson G, et al. Vaccination of cattle with a mycobacterial protein vaccine and BCG induces better protection against bovine tuberculosis than vaccination with BCG alone, Infect Immun 2005; in press.","DOI":"10.1128\/IAI.73.6.3540-3546.2005"},{"key":"10.1016\/j.vaccine.2005.04.022_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-1759(97)00102-6","article-title":"CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles","volume":"206","author":"Partidos","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2005.04.022_bib26","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0264-410X(98)00372-7","article-title":"Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers","volume":"17","author":"Venkataprasad","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0264-410X(97)00238-7","article-title":"Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T cell epitope of CS protein","volume":"16","author":"Nardin","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/infdis\/173.2.330","article-title":"A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine (The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group)","volume":"173","author":"Gorse","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.04.022_bib29","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.169.9.4905","article-title":"Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines","volume":"169","author":"Zeng","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0928-8244(97)00010-2","article-title":"Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: enhancement of the anti-melittin response by a synthetic T helper (Th)-cell epitope","volume":"17","author":"Hoffmann","year":"1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib31","first-page":"1477","article-title":"Vaccination with poly-l-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T cell responses against cancer antigens","volume":"62","author":"Mattner","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2005.04.022_bib32","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.169.9.5217","article-title":"Induction of specific immune responses by polycation-based vaccines","volume":"169","author":"Luhrs","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib33","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.4049\/jimmunol.148.10.3034","article-title":"Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes","volume":"148","author":"Wang","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2004.00138.x","article-title":"Progress in DNA-based heterologous prime-boost immunization strategies for malaria","volume":"199","author":"Moore","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2005.04.022_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-3083.2003.01218.x","article-title":"DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants","volume":"57","author":"Tollefsen","year":"2003","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib37","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nri959","article-title":"Progressive differentiation and selection of the fittest in the immune response","volume":"2","author":"Lanzavecchia","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib38","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1242\/jeb.00642","article-title":"Prime-boost strategies for malaria vaccine development","volume":"206","author":"Dunachie","year":"2003","journal-title":"J Exp Biol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib39","first-page":"171","article-title":"DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy","volume":"104","author":"Hill","year":"2000","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2005.04.022_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0264-410X(97)00226-0","article-title":"Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime\/MVA boost vaccination regime","volume":"16","author":"Hanke","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib41","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0264-410X(02)00085-3","article-title":"Development of a DNA-MVA\/HIVA vaccine for Kenya","volume":"20","author":"Hanke","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/14760584.3.3.299","article-title":"Developing an improved vaccine against tuberculosis","volume":"3","author":"McShane","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2005.04.022_bib43","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) T cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.022_bib45","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1099\/vir.0.19366-0","article-title":"Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes","volume":"84","author":"Hohlich","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2005.04.022_bib46","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1016\/S0264-410X(03)00364-5","article-title":"A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge","volume":"21","author":"Rodriguez","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.022_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/biol.2001.0302","article-title":"Synthetic peptide-based vaccine and diagnostic system for effective control of FMD","volume":"29","author":"Wang","year":"2001","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2005.04.022_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-2427(02)00154-X","article-title":"Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86)","volume":"88","author":"Patarroyo","year":"2002","journal-title":"Vet Immunol Immunopathol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05004652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05004652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:22:27Z","timestamp":1683094947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05004652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":48,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0264410X05004652"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.04.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}